GLSHQ (Gelesis Holdings) Other Long-Term Liabilities: $0.00 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Gelesis Holdings Other Long-Term Liabilities?

Gelesis Holdings GLSHQ -99.00% Other Long-Term Liabilities is $0.00 Mil as of Jun. 2023.

Gelesis Holdings's other long-term liabilities for the quarter that ended in Jun. 2023 was $0.00 Mil.

Gelesis Holdings's quarterly other long-term liabilities declined from Dec. 2022 ($1.24 Mil) to Mar. 2023 ($0.14 Mil) and declined from Mar. 2023 ($0.14 Mil) to Jun. 2023 ($0.00 Mil).

Gelesis Holdings's annual other long-term liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($317.00 Mil) but then declined from Dec. 2021 ($317.00 Mil) to Dec. 2022 ($1.24 Mil).

Gelesis Holdings Other Long-Term Liabilities Related Terms

Gelesis Holdings Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Gelesis Holdings's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelesis Holdings Other Long-Term Liabilities Chart

Gelesis Holdings Annual Data
Trend Dec21 Dec22
Other Long-Term Liabilities
317.00 1.24

Gelesis Holdings Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.01 7.20 1.24 0.14 0.00

Gelesis Holdings Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $0.00 Mil mean?
Gelesis Holdings (GLSHQ) has a Other Long-Term Liabilities of $0.00 Mil as of Jun. 2023. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gelesis Holdings and its competitors.
Is Gelesis Holdings' Other Long-Term Liabilities too high?
Gelesis Holdings' current Other Long-Term Liabilities is $0.00 Mil.
How does Gelesis Holdings' Other Long-Term Liabilities compare to RBSH and PPCB?
Gelesis Holdings' Other Long-Term Liabilities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gelesis Holdings and its competitors. Gelesis Holdings's current Other Long-Term Liabilities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gelesis Holdings stock overvalued right now?
Gelesis Holdings (GLSHQ) has a current Other Long-Term Liabilities of $0.00 Mil. The current Other Long-Term Liabilities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Gelesis Holdings (GLSHQ), the current Other Long-Term Liabilities is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gelesis Holdings Business Description

Address 501 Boylston Street, Suite 6102, Boston, MA, USA, 02116
Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.